Literature DB >> 1473021

Chronic intracerebral infusions of vasopressin and vasopressin antagonist modulate behavioral effects of interleukin-1 in rat.

R M Bluthé1, R Dantzer.   

Abstract

To assess the role of sex dependent brain vasopressinergic transmission in the modulation of the neural effects of interleukin-1, castrated male rats that are deficient in vasopressin were implanted intracerebroventricularly with an Accurel collodion mini device containing 10 micrograms AVP whereas intact male rats were implanted with a similar device containing 50 micrograms of dPTyr(Me)AVP, a specific antagonist of the vasopressor-like receptors of vasopressin. Control rats in each sex group were implanted with an Accurel device containing distilled water. Acute intracerebroventricular injection of 1.25-2.50 ng recombinant human interleukin-1 beta decreased in a dose and time-dependent manner social investigation of a juvenile conspecific. This effect was more intense in intact rats chronically infused with dPTyr(Me)AVP and less intense in castrates infused with AVP. These results confirm the modulatory role of sex-dependent vasopressinergic neurotransmission on the neural effects of interleukin-1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1473021     DOI: 10.1016/0361-9230(92)90162-q

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  3 in total

1.  The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy.

Authors:  W S Young; J Li; S R Wersinger; M Palkovits
Journal:  Neuroscience       Date:  2006-10-04       Impact factor: 3.590

2.  Sex differences in social investigation: effects of androgen receptors, hormones and test partner.

Authors:  L D Tejada; E F Rissman
Journal:  J Neuroendocrinol       Date:  2012-08       Impact factor: 3.627

3.  Love and fear in the times of sickness.

Authors:  Robert Dantzer
Journal:  Compr Psychoneuroendocrinol       Date:  2021-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.